Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$86,861
-$70,534 QoQ
Shares Held
9,221
-52.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 263 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$19,655,772
PutShares
2,086,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. NVAX ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
446,696 | $25,376,799 | |
| 2 | INCY |
Incyte Corp
|
15,632 | $1,772,043 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
16,717 | $1,325,490 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
22,114 | $862,667 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,256 | $679,123 | |
| 6 | ARVN |
Arvinas, Inc.
|
81,364 | $676,134 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
11,107 | $645,649 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
92,277 | $575,808 |
All Filings in NVAX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,861 | 9,221 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $19,655,772 | 2,086,600 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $16,984,924 | 2,086,600 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $157,395 | 19,336 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $272,966 | 40,620 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $17,005,632 | 2,530,600 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $22,107,633 | 2,549,900 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $59,510 | 6,864 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,434,370 | 2,449,900 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $214,162 | 33,994 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $639,019 | 99,691 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $2,846,040 | 444,000 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $3,569,760 | 444,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $490,126 | 60,961 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $701,773 | 55,564 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $5,607,720 | 444,000 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $5,621,040 | 444,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $999,367 | 78,939 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,248,416 | 1,307,200 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $3,364,800 | 701,000 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $3,394,112 | 468,800 | Put | Sole | 2023-11-22 | |
| 2023-06-30 | $3,036,641 | 408,700 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $4,884,957 | 704,900 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $822,400 | 80,000 | Put | Sole | 2023-02-14 | |
| 2021-12-31 | $30,230,691 | 211,300 | Put | Sole | 2022-02-14 | |
| 2021-09-30 | $10,365,500 | 50,000 | Put | Sole | 2021-11-15 | |
| 2020-12-31 | $4,188,538 | 37,562 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||